Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Human prostate cancer is characterized by multiple gross chromosome alterations involving several chromosome regions. However, the specific genes involved in the development of prostate tumors are still largely unknown. Here we have studied the chromosome composition of the three established prostate cancer cell lines, LNCaP, PC-3, and DU145, by spectral karyotyping (SKY). SKY analysis showed complex karyotypes for all three cell lines, with 87, 58/113, and 62 chromosomes, respectively. All cell lines were shown to carry structural alterations of chromosomes 1, 2, 4, 6, 10, 15, and 16; however, no recurrent breakpoints were detected. Compared to previously published findings on these cell lines using comparative genomic hybridization, SKY revealed several balanced translocations and pinpointed rearrangement breakpoints. The SKY analysis was validated by fluorescence in situ hybridization using chromosome-specific, as well as locus-specific, probes. Identification of chromosome alterations in these cell lines by SKY may prove to be helpful in attempts to clone the genes involved in prostate cancer tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Y translocations have been documented in cell lines, for example, in prostate cell line DU 145.48”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [48]
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Two types of chromosome translocation patterns have been suggested to be involved in human malignancy (Lengauer et al., 1998).”
BackgroundEstablishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,156
ISCN 1995 An international system for human cytogenetic nomenclature
Mitelman, F. (1995) · Cited by 1,930
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar-Am, I., Soenksen, D., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,755
Karyotyping human chromosomes by combinatorial multi-fluor FISH
Speicher, M. R., Ballard, S. G., & Ward, D. C. (1996) · Nature Genetics · doi:10.1038/ng0496-368 · Cited by 1,270
Isolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Wu, H., Hsieh, J., Gleave, M. E., Brown, N. M., Pathak, S., & Chung, L. W. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570319 · Cited by 499
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
Self-citationAllelic loss of chromosomes 16q and 10q in human prostate cancer.
Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., & Isaacs, W. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8751 · Cited by 457
Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B., & Bova, G. S. (1998) · PubMed · Cited by 452
Jenkins, R. B., Qian, J., Lieber, M. M., & Bostwick, D. G. (1997) · PubMed · Cited by 443
Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., & Jensen, R. H. (1996) · PubMed · Cited by 391
Veldman, T., Vignon, C., Schröck, E., Rowley, J. D., & Ried, T. (1997) · Nature Genetics · doi:10.1038/ng0497-406 · Cited by 350
Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas
Nupponen, N. N., Kakkola, L., Koivisto, P., & Visakorpi, T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65554-x · Cited by 307
Self-citationMulticolour spectral karyotyping of mouse chromosomes
Liyanage, M., Coleman, A., Manoir, S. D., Veldman, T., McCormack, S., Dickson, R. B., Barlow, C., Wynshaw-Boris, A., Janz, S., Wienberg, J., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-312 · Cited by 306
Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma
Bergerheim, U. S. R., Kunimi, K., Collins, V. P., & Ekman, P. (1991) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870030308 · Cited by 290
Self-citationMutation of the MXI1 gene in prostate cancer
Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B., & Prochownik, E. V. (1995) · Nature Genetics · doi:10.1038/ng0395-249 · Cited by 201
Ghadimi, B. M., Schröck, E., Walker, R. L., Wangsa, D., Jauho, A., Meltzer, P. S., & Ried, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65298-4 · Cited by 197
Rao, P. H., Cigudosa, J. C., Ning, Y., Calasanz, M. J., Iida, S., Tagawa, S., Michaeli, J., Klein, B., Dalla‐Favera, R., Jhanwar, S. C., et al. (1998) · Blood · doi:10.1182/blood.v92.5.1743 · Cited by 143
Treaty Draft Raises Scientific Hackles
Lawler, A. (1996) · Science · doi:10.1126/science.274.5287.494 · Cited by 132
Chromosomal abnormalities and related events in prostate cancer
Sandberg, A. A. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90083-f · Cited by 118
Berg, C. V. D., Guan, X., Hoff, D. V., Jenkins, R. B., Bittner, Griffin, C. A., Kallioniemi, O., Visakorpi, McGill, & Herath, J. F. (1995) · PubMed · Cited by 115
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization
Nupponen, N. N., Hyytinen, E., Kallioniemi, A. H., & Visakorpi, T. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00060-5 · Cited by 113
Self-citationTumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping
Ried, T., Liyanage, M., du Manoir, S., Heselmeyer, K. M., Auer, G., Macville, M. V. E., & Schröck, E. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050169 · Cited by 108
Visakorpi, T., HYYTINEN, E.-R., Kallioniemi, A. H., Isola, J. J., & Kallioniemi, O. (1994) · PubMed · Cited by 92
Self-citationChromosomal analysis of human prostatic adenocarcinoma cell lines.
Ohnuki, Y., Marnell, M., Babcock, M. S., Lechner, J. F., & Kaighn, M. E. (1980) · PubMed · Cited by 87
Commonly occurring loss and mutation of the MXI1 gene in prostate cancer
Prochownik, E. V., Grove, L. E., Deubler, D., Zhu, X. L., Stephenson, R. A., Rohr, L. R., Yin, X., & Brothman, A. R. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199808)22:4<295::aid-gcc5>3.3.co;2-r · Cited by 85
Chromosomal clues to the development of prostate tumors
Brothman, A. R., Maxwell, T. M., Jiang, C., Deubler, D. A., & Zhu, X. L. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.0.co;2-e · Cited by 84
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.
Matsuyama, H., Pan, Y., Skoog, L. K., Tribukait, B., Naito, K., Ekman, P., Lichter, P., & Bergerheim, U. S. R. (1994) · PubMed · Cited by 80
Self-citationA high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP)
Gibas, Z., Becher, R., KAWINSKI, E., Horoszewicz, J. S., & Sandberg, A. A. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90020-7 · Cited by 79
Genetic Basis and Clonal Evolution of Human Prostate Cancer
Kallioniemi, O., & Visakorpi, T. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60355-3 · Cited by 68
Self-citationMolecular genetics of prostate cancer.
Isaacs, W. B. (1995) · PubMed · Cited by 57
Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients
Carles, J., Domènech, M., Gelabert-Más, A., Nogué, M., Tabernero, J. M., Arcusa, A., Guasch, I., Miguel, A., Ballesteros, J. J., & Fabregat, X. (1998) · Acta Oncologica · doi:10.1080/028418698429757 · Cited by 49
Dna Flow Cytometry in Carcinoma of the Prostate for Diagnosis, Prognosis and Study of Tumor Biology
Tribukait, B. (1991) · Acta Oncologica · doi:10.3109/02841869109092348 · Cited by 48
Pan, Y., Matsuyama, H., Wang, N., Yoshihiro, S., Häggarth, L., Li, C., Tribukait, B., Ekman, P., & Bergerheim, U. S. R. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980615)36:1<31::aid-pros5>3.0.co;2-e · Cited by 38
Self-citationKönig, J. J., Teubel, W. J., Kamst, E., Romijn, J. C., Schröder, F. H., & Hagemeijer, A. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00224-0 · Cited by 22
Visakorpi, T., Koivula, T., Kylmälä, T., Tainio, H., Tammela, T. L. J., & Isola, J. J. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80037-1 · Cited by 6
Self-citation(1999) · PubMed
Research works printed but not linked: 1
- 10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.3.co;2-5 · doi:10.1002/(sici)1097-0045(19990301)38:4<303::aid-pros6>3.3.co;2-5
Cited by
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C.-H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,634
Molecular characterization of human prostate carcinoma cell lines
van Bokhoven, A., Varella‐Garcia, M., Korch, C., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 633
Upregulation of Cyclin B1 by miRNA and its implications in cancer
Huang, V., Place, R. F., Portnoy, V., Wang, J., Qi, Z., Jia, Z., Yu, A., Shuman, M., Yu, J., & Li, L.-C. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr934 · Cited by 289
Prostate cancer between prognosis and adequate/proper therapy.
Grozescu, T., & Popa, F. (2017) · PubMed Central · Cited by 177
Telomere dysfunction, genome instability and cancer
Cheung, A. (2008) · Frontiers in Bioscience · doi:10.2741/2825 · Cited by 139
Metadata
- Authors
- Pan, Y., Kytölä, S., Farnebo, F., Wang, N., Lui, W. O., Nupponen, N., Isola, J., Visakorpi, T., Bergerheim, U. S. R., & Larsson, C.
- Affiliations
- Karolinska University Hospital (SE)
- Tampere University Hospital (FI)
- Venue
- Cytogenetic and Genome Research
- Publisher
- S. Karger AG
- Published
- 1999
- Volume
- 87
- Issue
- 3-4
- Pages
- 225-232
- ISSN
- 1424-859X (ISSN-L)
- 1424-8581
- OpenAlex
- W1975308167
- Cited by
- 63
- References
- 39
- Citations by year
- 2026: 2 · 2024: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cytogenetic and Genome Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genome Rearrangement Algorithms
- Keywords
- prostate cancer, chromosomal abnormalities, spectral karyotyping, prostate cancer cell lines, LNCaP cells, PC-3 cells, DU145 cells, balanced translocation, chromosomal rearrangements
- MeSH terms
- Aneuploidy, Chromosome Aberrations, Chromosomes, Human, Pair 8, Humans, Karyotyping, Male, Nucleic Acid Hybridization, Prostatic Neoplasms, Translocation, Genetic, Tumor Cells, Cultured, Reproducibility of Results, In Situ Hybridization, Fluorescence, Chromosome Breakage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.